AccuGenomics is a developer of a unique spike-in control technology that dramatically improves the accuracy and performance of clinical sequencing tests for low abundance biomarkers such as circulating tumor DNA (ctDNA) and low titer infectious pathogens such as SARS-CoV-2. Standardized Nucleic Acid Quantification for Sequencing (SNAQ™-SEQ) is an innovative QC method that uses mixtures of synthetic DNA or RNA internal standards (MIS™) spiked into each sample prior to NGS library prep. Being mixed with the sample and biochemically identical to the regions of interest, these standards undergo the same processing, handling and reaction conditions as the sample does, to provide the ideal run control approach for NGS-based assays. SNAQ-SEQ spike-in controls provide much higher confidence in the results of sequencing tests, eliminate false positives and dramatically reduce false negatives resulting in better overall accuracy as compared to using external (or no) controls alone.
View Top Employees from AccuGenomicsWebsite | http://accugenomics.com |
Revenue | $6 million |
Employees | 7 (3 on RocketReach) |
Address | 1410 COMMONWEALTH DR STE 105, Wilmington, North Carolina 28403, US |
Phone | (910) 200-3228 |
Fax | (910) 679-4263 |
Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Business Services |
Competitors | Contextual Genomics, Everist Health, Mobidiag, A Hologic Company, Rosetta Genomics, Silver Lake Research |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies |
Looking for a particular AccuGenomics employee's phone or email?
The AccuGenomics annual revenue was $6 million in 2024.
3 people are employed at AccuGenomics.
AccuGenomics is based in Wilmington, North Carolina.
The NAICS codes for AccuGenomics are [541, 54171, 5417, 54, 541714].
The SIC codes for AccuGenomics are [87, 873].